Big Pharma spent record $27.5 million on lobbying in 2018
The surge in spending comes as the pharma industry prepares for what could be its most challenging year in decades.
By Bill Allison|January 25, 2019 at 07:46 AM
Thank you for sharing!
Your article was successfully shared with the contacts you provided.
The pharmaceutical industry’s leading trade group disclosed Tuesday that it had spent a record $27.5 million on lobbying in 2018, $1.4 million more than in 2009, when Congress and the White House created the Affordable Care Act, the health-care overhaul better known as Obamacare.
The surge in spending by the Pharmaceutical Research and Manufacturers of America came as the industry failed to win a last-minute legislative fix that would have reduced its share of outlays in a popular Medicare program, and as it prepared for what could be its most challenging year in decades.
Complete your profile to continue reading and get FREE access to BenefitsPRO.com, part of your ALM digital membership.
Your access to unlimited BenefitsPRO.com content isn’t changing. Once you are an ALM digital member, you’ll receive:
Critical BenefitsPRO.com information including cutting edge post-reform success strategies, access to educational webcasts and videos, resources from industry leaders, and informative Newsletters.
Exclusive discounts on ALM, BenefitsPRO magazine and BenefitsPRO.com events.
Access to other award-winning ALM websites including ThinkAdvisor.com and Law.com
'Tis the season for changes to primary medical plans. Download this infographic and learn 4 actionable solutions to help save your clients from the gloom of a new primary plan reality before it's too late.